Article Details

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder

Retrieved on: 2020-01-03 00:30:00

Tags for this article:

Click the tags to see associated articles and topics

Clinical Program Started for Agitation with Schizophrenia, Bipolar Disorder. View article details on hiswai:

Excerpt

<div>H.C. Wainwright & Co. has a Buy rating and a 12-month target price of $25 per share on BioXcel, whose <b>stock</b> is now trading at around $13.60 per ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up